# Low-dose Theophylline as Anti-inflammatory Enhancer in Severe Chronic Obstructive Pulmonary Disease

> **NCT01599871** · PHASE3 · COMPLETED · sponsor: **Hospital Son Espases** · enrollment: 70 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** theophylline
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01599871
- **Lead sponsor:** Hospital Son Espases
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2015-12
- **Final completion:** 2016-09
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2017-08-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01599871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01599871, "Low-dose Theophylline as Anti-inflammatory Enhancer in Severe Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01599871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*